Rita Pinto

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategy.

Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategy.

Journal: Oncogene
Published: July 10, 2025

From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies.

From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies.

Journal: Oncogene
Published: April 23, 2025

Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework.

Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework.

Journal: Molecular oncology
Published: April 19, 2024

Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus.

Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus.

Journal: Clinical epigenetics
Published: July 02, 2021

Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability.

Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability.

Journal: International journal of cancer
Published: July 08, 2020

Human METTL18 is a histidine-specific methyltransferase that targets RPL3 and affects ribosome biogenesis and function.

Human METTL18 is a histidine-specific methyltransferase that targets RPL3 and affects ribosome biogenesis and function.

Journal: Nucleic acids research
Published: May 08, 2020

The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes.

The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes.

Journal: Nature communications
Published: February 24, 2020

A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis.

A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: January 04, 2020

Human FAM173A is a mitochondrial lysine-specific methyltransferase that targets adenine nucleotide translocase and affects mitochondrial respiration.

Human FAM173A is a mitochondrial lysine-specific methyltransferase that targets adenine nucleotide translocase and affects mitochondrial respiration.

Journal: The Journal of biological chemistry
Published: April 25, 2019

The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA.

The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA.

Journal: Nucleic acids research
Published: April 03, 2019

Lysine methylation by the mitochondrial methyltransferase FAM173B optimizes the function of mitochondrial ATP synthase.

Lysine methylation by the mitochondrial methyltransferase FAM173B optimizes the function of mitochondrial ATP synthase.

Journal: The Journal of biological chemistry
Published: August 22, 2018

The dual methyltransferase METTL13 targets N terminus and Lys55 of eEF1A and modulates codon-specific translation rates.

The dual methyltransferase METTL13 targets N terminus and Lys55 of eEF1A and modulates codon-specific translation rates.

Journal: Nature communications
Published: December 01, 2017
Showing 1-12 of 13

Last Updated: 09/26/2026